Drug intelligence / Profile preview

alflutop

Development stage
Unknown
Lead developer
BIOTEHNOS
Administration
Intramuscular, Intraarticular
01

Overview

Alflutop is an injectable chondroprotective drug derived from a bioactive concentrate of small marine fish. Its formulation contains mucopolysaccharides (notably chondroitin sulfate), amino acids, peptides, and minerals such as sodium, potassium, calcium, magnesium, iron, copper, and zinc. Alflutop acts by inhibiting hyaluronidase activity, thus protecting and stimulating the biosynthesis of hyaluronic acid, which is essential for joint fluid and cartilage integrity. The drug promotes tissue regeneration, reduces pain through an analgesic effect, and demonstrates anti-inflammatory activity. The primary indications are osteoarthritis (both primary and secondary forms), spondylosis, and osteochondrosis. It is reported to improve joint function, reduce pain, and retard disease progression in osteoarthritic patients. Alflutop is administered via intramuscular and intra-articular injections[1][3][5][6][7][8].

Brand names
Alflutop
02

Targets

HYAL (Hyaluronidase family (HYAL))

Beyond the preview

Go deeper on alflutop.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alflutop.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call